Zum Intranet Zurück zur Startseite. Kontakt Suchmaschine
CC4 - CharitéCentrum 4 für Therapieforschung
... > Arbeitsgruppe Prof. Dr. Ralf Stahlmann > english > Publications > A. Referierte Originalarbeiten

 

Zurück zu "Publications". Publications
Sie betrachten gerade "A. Referierte Originalarbeiten". A. Referierte Originalarbeiten
Zum kompletten Inhaltsverzeichnis. Inhaltsverzeichnis

 

A. Referierte Originalarbeiten

1995 1996 1997 1998 1999 request reprint
2000 2001 2002 2003 2004
2005 2006 2007 2008 2009
2010 2011      

    1995
  1. Shakibaei M, Förster C, Merker H J, Stahlmann R (1995) Effects of ofloxacin on integrin expression on epiphyseal mouse chondrocytes in vitro. Toxic in vitro 9:107-116
  2. Stahlmann R, Neubert R (1995) Value of non-human primate data (Intl. Workshop on Environmental Immunotoxicology and Human Health) Hum Exp Toxicol 14:146-147
  3. Förster C, Shakibaei M, Schilcher H, Stahlmann R (1995) Expression of ß1-integrins on epiphyseal chondrocytes is reduced by ofloxacin. Drugs 49 (Suppl 2): 279-282
  4. Shakibaei M, Förster C, Merker H-J, Stahlmann R (1995) Ofloxacin alters expression of integrins on chondrocytes from mouse fetuses in vitro. Drugs 49 (Suppl 2): 293-295
  5. Stahlmann R, Förster C, Shakibaei M, Vormann J, Günther T, Merker H-J (1995) Magnesium deficiency induces joint cartilage lesions in juvenile rats which are identical to quinolone-induced arthropathy. Antimicrob Agents Chemother 39: 2013-2018
  6. Schulz TG, Stahlmann R, Edwards RJ, Debris K, Davies DS, Neubert D (1995) Enoxacin is an inducer of CYP1A2 in rat liver. Biochem Pharmacol 50: 1517-1520

    7. go top Anfang/top

    1996

  7. Förster C, Kociok K, Shakibaei M, Merker H-J, Vormann J, Günther T, Stahlmann R (1996) Integrins on joint cartilage chondrocytes and alterations by ofloxacin or magnesium deficiency in immature rats. Arch Toxicol 70: 261-270
  8. Förster C, Kociok K, Shakibaei M, Merker H-J, Stahlmann R (1996) Quinolone-induced cartilage lesions are not reversible in rats. Arch Toxicol 70: 474-481
  9. Shakibaei M, Kociok K, Förster C, Vormann J, Günther T, Stahlmann R, Merker H-J (1996) Comparative evaluation of ultrastructural changes in articular cartilage of ofloxacin-treated and magnesium-deficient immature rats. Toxicol Pathol 24: 580-587

    10. go top Anfang/top

    1997

  10. Günther T, Rücker M, Förster C, Vormann J, Stahlmann R (1997) In vitro evidence for a Donnan distribution of Mg2+ and Ca2+ by chondroitin sulfate in cartilage. Arch Toxicol 71: 471-475
  11. Vormann J, Förster C, Zippel U, Lozo E, Günther T, Merker HJ, Stahlmann R (1997) Effects of magnesium deficiency on magnesium and calcium content in bone and cartilage in developing rats in correlation to chondrotoxicity. Calc Tiss Intl 61: 230-238
  12. Förster C, Schwabe R, Lozo E, Zippel U,Vormann J, Günther T, Merker HJ, Stahlmann R (1997) Quinolone-induced arthropathy: Exposure of magnesium-deficient aged rats or immature rats, mineral concentrations in target tissues and pharmacokinetics. Arch Toxicol 72: 26 -32
  13. Burkhardt JE, Förster C, Lozo E, Hill MA, Stahlmann R (1997) Immunohistochemistry of articular cartilage from immature Beagle dogs dosed with difloxacin. Toxicol Pathol 25: 475-480

    14. go top Anfang/top

    1998

  14. Stahlmann R, Zippel U, Förster C, Schwabe R, Shakibaei M, Merker HJ, Borner K (1998) Chondrotoxicity and toxicokinetics of sparfloxacin in juvenile rats. Antimicrob Agents Chemother 42: 1470-1475
  15. Förster C, Rücker M, Shakibaei M, Baumann-Wilschke I, Vormann J, Stahlmann R (1998) Effects of fluoroquinolones and magnesium deficiency in murine limb bud cultures. Arch Toxicol 72: 411-419
  16. Stahlmann R, Lode H (1998) Safety of quinolones. The Lancet (Letter) 352/9136: 1313

    17. go top Anfang/top

    1999

  17. Stahlmann R, Schwabe R, Pfister K, Lozo E, Shakibaei M, Vormann J (1999) Supplementation with magnesium and tocopherol diminishes quinolone-induced chondrotoxicity in immature rats. Drugs 58 (Suppl 2): 393-394
  18. Stahlmann R, Kühner S, Shakibaei M, Schwabe R, van Sickle D (1999) Chondrotoxicity of ciprofloxacin in immature Beagle dogs. Drugs 58 (Suppl 2): 388-389
  19. Schwabe R, Lozo E, Baumann-Wilschke I, Stahlmann R (1999) Chondrotoxicity and target tissue kinetics of ofloxacin in immature rats after multiple doses. Drugs 58 (Suppl 2): 385-387
  20. Stahlmann R, Lode H (1999) Toxicity of quinolones. Drugs 58 (Suppl 2): 37-42
  21. Shakibaei M, Pfister K, Schwabe R, Stahlmann R (1999) Effects of ofloxacin on the ultrastructure of Achilles tendon in rats. Drugs 58 (Suppl 2): 390-392
  22. Riecke K, Stahlmann R, Palavinskas R, Alexi-Meskishvili V, Mathar W (1999) Polychlorinated dibenzodioxins and polychlorinated dibenzofurans in juvenile human thymus. Organohalogen Compounds 44: 233-236

    23. go top Anfang/top

    2000

  23. Stahlmann R, Kühner S, Shakibaei M, Schwabe R, Flores J, Evander SA, van Sickle DC (2000) Chondrotoxicity of ciprofloxacin in immature Beagle dogs: immunohistochemistry, electron microscopy and drug plasma concentrations. Arch Toxicol 73: 564-572
  24. Stahlmann R, Kühner S, Shakibaei M, Flores J, Vormann J, van Sickle DC (2000) Effects of magnesium deficiency on joint cartilage in immature Beagle dogs: immunohistochemistry, electron microscopy and mineral concentrations. Arch Toxicol 73: 573-580
  25. Shakibaei M, Pfister K, Schwabe R, Vormann J, Stahlmann R (2000) Ultrastructure of Achilles tendons of rats treated with ofloxacin and fed a normal or magnesium-deficient diet. Antimicrob Agents Chemother 44/2: 261-266
  26. Riecke K, Schulz TG, Shakibaei M, Krause B, Chahoud I, Stahlmann R (2000) Developmental toxicity of the HIV-protease inhibitor indinavir in rats. Teratology 62: 291-300
  27. Riecke K, Nogueira AC, Alexi-Meskishvili V, Stahlmann R (2000) Cross reactivity of antibodies on thymic epithelial cells from humans and marmosets by flow-cytometry. J Med Primatol 29: 343-349 

    28. go top Anfang/top

    2001

  28. Thiel R, Metzner S, Gericke C, Rahm U, Stahlmann R (2001) Effects of fluoroquinolones on the locomotor activity in rats. Arch Toxicol 75: 36-41
  29. Shakibaei M, Stahlmann R (2001) Ultrastructure of Achilles tendon from rats after treatment with fleroxacin. Arch Toxicol 75: 97-102
  30. Shakibaei M, de Souza P, van Sickle D, Stahlmann R (2001) Biochemical changes in Achilles tendon from juvenile dogs after treatment with ciprofloxacin or feeding a magnesium-deficient diet. Arch Toxicol 75: 369-374

    31. go top Anfang/top

    2002

  31. Shakibaei M, Baumann-Wilschke I, Rücker M, Stahlmann R (2002) Ultrastructural characterization of murine limb buds after in vitro exposure to grepafloxacin and other fluoroquinolones. Arch Toxicol 75: 725-733.
    PMID: 11876506
  32. Lozo E, Riecke K, Schwabe R, Vormann J, Stahlmann R (2002) Synergistic effect of ofloxacin and magnesium deficiency on joint cartilage in immature rats. Antimicrob Agents Chemother 46: 1755-1759.
    PMID: 12019086
  33. Riecke K, Grimm D, Shakibaei M, Kossmehl P, Schulze-Tanzil G, Paul M, Stahlmann R (2002) Low doses of 2,3,7,8-tetrachlorodibenzo-p-dioxin increase transforming growth factor ß and cause myocardial fibrosis in marmosets (Callithrix jacchus). Arch Toxicol 76: 360-366.
    PMID: 12107654      
  34. Riecke K, Grimm D, Shakibaei M, Kossmehl P, Schulze-Tanzil G, Paul M, Stahlmann R (2002) 2,3,7,8-Tetrachloro-dibenzo-p-dioxin induces myocardial fibrosis in marmosets (Callithrix jacchus). Organohalogen Compounds 55: 351-354. 
  35. Kappel EM, Shakibaei M, Bello A, Stahlmann R (2002) Effects of the des-F(6)-quinolone garenoxacin (BMS-284756), in comparison to those of ciprofloxacin and ofloxacin, on joint cartilage in immature rats. Antimicrob Agents Chemother 46: 3320-3322.
    PMID: 12234871
  36. Stahlmann R, Lode H (2002) Fluoroquinolones in the elderly: Safety considerations. Drugs and Aging, in press
  37. Pechere JC, Cenedese C, Muller O, Perez-Gorricho B, Ripoll M, Rossi A, Stahl JP, Stahlmann R, Tramarin A.
    38. Attitudinal classification of patients receiving antibiotic treatment for mild respiratory tract infections. Int J Antimicrob Agents. 2002 Dec;20(6):399-406.
    PMID: 12458132
  38. Stahlmann R. Clinical toxicological aspects of fluoroquinolones. Toxicol Lett. 2002 Feb 28;127(1-3):269-77.
    PMID: 12052667
  39. Platzek T, Stahlmann R, Wegener M, Lang C (2002) Allergene in kosmetischen Mitteln, Waschmitteln und Textilien. Mitt Lebensm Hyg 93: 591-616.

    40. go top Anfang/top

    2003

  40. Stahlmann R (2002) Children as a special population at risk - quinolones as an example for xenobiotics exhibiting skeletal toxicity. Arch Toxicol. 2003 Jan;77(1):7-11.
    PMID: 12491034
  41. Schwenk M, Gundert-Remy U, Heinemeyer G, Olejniczak K, Stahlmann R, Kaufmann W, Bolt HM, Greim H, Von Keutz E, Gelbke HP. Children as a sensitive subgroup and their role in regulatory toxicology: DGPT workshop report.
    42. Arch Toxicol. 2003 Jan;77(1):2-6.
    PMID: 12491033
  42. Stahlmann R, Lode H (2003) Fluoroquinolones in the elderly: Safety considerations. Drugs and Aging 20: 289-302.
    PMID: 12641485
  43. Riecke K, Schmidt A, Stahlmann R (2003) Effects of 2,3,7,8-TCDD and PCB 126 on human thymic epithelial cells in vitro. Arch Toxicol 77: 358-364.
    PMID: 12799776
  44. Müller O, Stahlmann R (2003) Patientenerwartungen und Compliance bei der antibiotischen Therapie von Infektionen der oberen Atemwege. Chemother J 12: 13-20.
  45. Shakibaei M, Stahlmann R (2003) Ultrastructural Changes Induced by the Des-F(6)-Quinolone Garenoxacin (BMS-284756) and Two Fluoroquinolones in Achilles Tendon from Immature Rats. Arch Toxicol 77: 521-526.
    PMID: 12811465

    46. go top Anfang/top

    2004

  46. Kastner M, Rahm U, Baumann-Wilschke I, Bello A, Stahlmann R (2004) Concentrations of the Des-F(6)-quinolone garenoxacin in plasma and joint cartilage of immature rats. Arch Toxicol 78: 61-67.
    PMID:14661070
  47. Ball P, Stahlmann R, Kubin R, Choudhri S, Owens R. (2004) Safety profile of oral and intravenous moxifloxacin: cumulative data from clinical trials and postmarketing studies. Clin Ther. 2004 Jul;26(7):940-50.
    PMID: 15336463 [PubMed - in process]
  48. Ulbrich B, Stahlmann R. (2004) Developmental toxicity of polychlorinated biphenyls (PCBs): a systematic review of experimental data. Arch Toxicol. 2004 May;78(5):252-68. Epub 2004 Apr 02. Review.
    PMID: 15064922 [PubMed - in process] - REVIEW | ELECTRONIC MATERIAL
  49. Stahlmann R, Sendzik J. (2004) [Adverse effects of anti-infectives. Undesirable effects and interactions of ketolides and oxazolidonones] Pharm Unserer Zeit. 2004;33(1):48-54. Review. German. No abstract available.
    PMID: 14968713 [PubMed - indexed for MEDLINE]

    50. go top Anfang/top

    2005

  50. Oberemm A, Meckert C, Brandenburger L, Herzig A, Lindner Y, Kalenberg K, Krause E, Ittrich C, Kopp-Schneider A, Stahlmann R, Richter-Reichhelm HB, Gundert-Remy U. Differential signatures of protein expression in marmoset liver and thymus induced by single-dose TCDD treatment. Toxicology. 2005 Jan 5;206(1):33-48.
    PMID: 15590107 [PubMed - in process]
  51. Sendzik J, Stahlmann R (2005) Arzneimittel gegen Kopflausbefall, Toxikologie und Wirksamkeit. MMP 28:167
  52. Sendzik J, Shakibaei M, Schäfer-Korting M, Stahlmann R (2005) Fluoroquinolones cause changes in extracellular matrix, signalling proteins, metalloproteinases and caspase-3 in cultured human tendon cells. Toxicology. 2005 May 9; [Epub ahead of print]
    PMID: 15890441 [PubMed - as supplied by publisher]
  53. Kilic B, Kruse M, Stahlmann R. The in-vitro effects of quinupristin/dalfopristin, erythromycin and levofloxacin at low concentrations on the expression of different cell adhesion molecules on the surface of endothelial cells (Eahy926). Toxicology. 2006 Jan 20;218(1):30-8. Epub 2005 Nov 16.
    PMID: 16297520 [PubMed - indexed for MEDLINE]

    54. go top Anfang/top

    2006

  54. Stahlmann R, Wegner M, Riecke K, Kruse M, Platzek T. Sensitising potential of four textile dyes and some of their metabolites in a modified local lymph node assay. Toxicology. 2006 Feb 15;219(1-3):113-23.
    PMID: 16388883 [PubMed - in process]
  55. Nottebrock C, Riecke K, Kruse M, Shakibaei M, Stahlmann R. Effects of 2,3,7,8-tetrachloro-dibenzo-p-dioxin on the extracellular matrix of the thymus in juvenile marmosets (Callithrix jacchus). Toxicology. 2006 Sep 21;226(2-3):197-207. Epub 2006 Jul 14.
    PMID: 16920245 [PubMed - in process]
  56. Kruse M, Kilic B, Flick B, Stahlmann R. Effect of quinupristin/dalfopristin on 3T3 and Eahy926 cells in vitro in comparison to other antimicrobial agents with the potential to induce infusion phlebitis. Arch Toxicol. 2006 Nov 22; [Epub ahead of print]
    PMID: 17119926 [PubMed - as supplied by publisher]

    57. go top Anfang/top

    2007

  57. Pfister K, Mazur D, Vormann J, Stahlmann R. Diminished Ciprofloxacin-Induced Chondrotoxicity by Supplementation of Magnesium and Vitamin E in Immature Rats. Antimicrob Agents Chemother. 2007 Jan 8; [Epub ahead of print]
    PMID: 17210779 [PubMed - as supplied by publisher]
  58. Schreiner M, Peiser M, Briechle D, Stahlmann R, Zuberbier T, Wanner R. A loose-fit coculture of activated keratinocytes and dendritic cell-related cells for prediction of sensitizing potential. Allergy. 2007 Dec;62(12):1419-28.
    PMID: 17983376 [PubMed - in process]

    59. go top Anfang/top

    2008

  59. Mazur D, Stahlmann R.
    [Drug-induced adverse pulmonary reactions]
    Dtsch Med Wochenschr. 2008 Jan;133(3):81-6. German. No abstract available.
    PMID: 18186010 [PubMed - in process]
  60. Lode HM, Schmidt-Ionas M, Stahlmann R.
    Gemifloxacin for community-acquired pneumonia. Expert Opin Investig Drugs. 2008 May;17(5):779-86.
    PMID: 18447602 [PubMed - in process]
  61. Schreiner M, Peiser M, Briechle D, Stahlmann R, Zuberbier T, Wanner R.
    A new dendritic cell type suitable as sentinel of contact allergens. Toxicology. 2008 May 4. [Epub ahead of print]
    PMID: 18547706 [PubMed - as supplied by publisher]
  62. Sendzik J, Lode H, Stahlmann R.
    Quinolone-induced arthropathy: an update focusing on new mechanistic and clinical data. Int J Antimicrob Agents. 2008 Oct 1. [Epub ahead of print]
    PMID: 18835137 [PubMed - as supplied by publisher]

    63. go top Anfang/top

    2009

  63. Ahuja V, Schreiber C, Platzek T, Stahlmann R.
    Investigation of the sensitising and cross-sensitising potential of textile dyes and beta-lactam antibiotics using a biphasic mice local lymph node assay. Arch Toxicol. 2009 Feb 11. [Epub ahead of print]
    PMID: 19212757 [PubMed - as supplied by publisher]
  64. Ahuja V, Wanner R, Platzek T, Stahlmann R.
    Appraisal of the sensitising potential of orally and dermally administered Mercaptobenzothiazol by a biphasic protocol of the local lymph node assay. Arch Toxicol. 2009 Apr 19. [Epub ahead of print]
    PMID: 19381614 [PubMed - as supplied by publisher]
  65. Millrose M, Kruse M, Flick B, Stahlmann R.
    Effects of macrolides on proinflammatory epitops on endothelial cells in vitro. Arch Toxicol. 2009 May;83(5):469-76. Epub 2008 Dec 4. [Epub ahead of print]
    PMID: 19052724 [PubMed - as supplied by publisher]
  66. Ahuja V, Eisenblätter M, Ignatius R, Stahlmann R.
    Ammonium perfluorooctanoate substantially alters phenotype and cytokine secretion of human monocyte-derived dendritic cells in vitro. Immunopharmacol Immunotoxicol. 2009;31(4):641-6.
    PMID: 19874235 [PubMed - in process]
  67. Breitschaft A, Stahlmann R.
    [Nephrogenic systemic fibrosis]. Med Monatsschr Pharm. 2009 Oct;32(10):377-82. Review. German.
    PMID: 19886227 [PubMed - indexed for MEDLINE]
  68. Bode K, Kunz A, Baumann-Wilschke I, Shakibaei M, Stahlmann R.
    Effects of moxifloxacin and clinafloxacin on murine limb buds cultured in regular and in magnesium-deficient medium. Arch Toxicol. 2009 Dec 1. [Epub ahead of print]
    PMID: 19949773 [PubMed - as supplied by publisher]
  69. Sendzik J, Shakibaei M, Schäfer-Korting M, Lode H, Stahlmann R.
    Synergistic effects of dexamethasone and quinolones on human-derived tendon cells. Int J Antimicrob Agents. 2009 Dec 22. [Epub ahead of print]
    PMID: 20034766 [PubMed - as supplied by publisher]

    70. go top Anfang/top

    2010

  70. Eckardt K, Stahlmann R.
    Use of two validated in vitro tests to assess the embryotoxic potential of mycophenolic acid. Arch Toxicol. 2010 Jan;84(1):37-43. Epub 2009 Oct 25.
    PMID: 19856175 [PubMed - in process]
  71. Wanner R, Sonnenburg A, Quatchadze M, Schreiner M, Peiser M, Zuberbier T, Stahlmann R.
    Classification of sensitizing and irritative potential in a combined in-vitro assay. Toxicol Appl Pharmacol. 2010 Mar 8. [Epub ahead of print]
    PMID: 20219181 [PubMed - as supplied by publisher]
  72. Stahlmann R, Lode H.
    Safety considerations of fluoroquinolones in the elderly: an update. Drugs Aging. 2010 Mar 1;27(3):193-209. doi: 10.2165/11531490-000000000-00000.
    PMID: 20210367 [PubMed - in process]
  73. Bode K, Kunz A, Baumann-Wilschke I, Shakibaei M, Stahlmann R. Effects of moxifloxacin and clinafloxacin on murine limb buds cultured in regular and in magnesium-deficient medium. Arch Toxicol. 2010 Mar;84(3):221-6. Epub 2009 Dec 1. PubMed
    PMID: 19949773.
  74. Ahuja V, Platzek T, Fink H, Sonnenburg A, Stahlmann R. Study of the sensitising potential of various textile dyes using a biphasic murine local lymph node assay. Arch Toxicol. 2010 Sep;84(9):709-18. Epub 2010 Jun 29.
    PubMed PMID: 20585758    .
  75. Sendzik J, Shakibaei M, Schäfer-Korting M, Lode H, Stahlmann R. Synergistic effects of dexamethasone and quinolones on human-derived tendon cells. Int J Antimicrob Agents. 2010 Apr;35(4):366-74. Epub 2010 Jan 19.
    PubMed PMID: 20034766    .
  76. Breitschaft A, Stahlmann R. [Nephrogenic systemic fibrosis]. Med Monatsschr Pharm. 2009 Oct;32(10):377-82. Review. German.
    PubMed PMID: 19886227.
  77. Mielke H, Anger LT, Schug M, Hengstler JG, Stahlmann R, Gundert-Remy U. A physiologically based toxicokinetic modelling approach to predict relevant concentrations for in vitro testing. Arch Toxicol. 2010 Nov 3. [Epub ahead of print]
    PubMed PMID: 21046363    .
  78. Ahuja V, Quatchadze M, Ahuja V, Stelter D, Albrecht A, Stahlmann R. Evaluation of biotechnology-derived novel proteins for the risk of food-allergic potential: advances in the development of animal models and future challenges. Arch Toxicol. 2010 Dec;84(12):909-17. Epub 2010 Sep 15. Review.
    PubMed PMID: 20842347    .

    79. go top Anfang/top

    2011

  79. Ju Q, Fimmel S, Hinz N, Stahlmann R, Xia L, Zouboulis CC. 2,3,7,8-Tetrachlorodibenzo-p-dioxin alters sebaceous gland cell differentiation in vitro. Exp Dermatol. 2011 Apr;20(4):320-5. doi: 10.1111/j.1600-0625.2010.01204.x.
    PubMed PMID: 21410761    .

 

 

Zurück zum vorherigen Abschnitt "Publications".  Zurück Weiter  Weiter zum nächsten Abschnitt "B. Übersichtsarbeiten / Reviews".



Weiterbildung
Hier finden Sie Informationen zum DGPT-Weiterbildungskurs Fremdstoffallergie/ Immuntoxikologie 2012
Hier finden Sie Informationen zum DGPT-Weiterbildungskurs Reproduktionstoxikologie 2012

Unser IntraNet
Zugang nur für Mitarbeiter des Institutes

- Impressum -
WWW-Verantwortlicher: Harald Weinrich

Haftungsausschluß für externe Links: Diese Webseite kann externe Links (nicht Bestandteil der Domäne www.charite.de) enthalten. Hierfür übernimmt die Charité keinerlei redaktionelle oder inhaltliche Verantwortung.

Letzte Änderung:
10. Februar 2012,
11:20:43.

© 2005: Charité.